Last checked at 
16 Mar 2018 16:34
16 March 2018
IMPACT HEALTHCARE REIT PLC
("Impact" or the "Company")
NOTICE OF FULL YEAR RESULTS
The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of healthcare real estate assets, will announce its full year results for the 12 months ended 31 December 2017 on Wednesday, 21 March 2018.
A Company presentation to analysts and investors will be held at 11.00 a.m. on the day at the offices of Newgate, Sky Light City Tower, 50 Basinghall Street, London, EC2V 5DE. The presentation will also be accessible via a live conference call and on-demand via the Company website: http://www.impactreit.uk/documents
Those wishing to attend the presentation or access the live conference call are kindly asked to contact Newgate at impact@newgatecomms.com or by telephone on +44 (0) 20 7680 6550.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP Mahesh Patel Andrew Cowley | via Newgate Communications |
Winterflood Securities Limited Joe Winkley Neil Langford | Tel: 020 3100 0000 |
Newgate Communications (PR Adviser) James Benjamin Anna Geffert Leena Patel | Tel: 020 7680 6550 Email: impact@newgatecomms.com |
The Company's LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at www.impactreit.uk.
NOTES:
The Group is a real estate investment trust ("REIT") which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of healthcare real estate opportunities, in particular residential care homes. The Group's investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.
The Group is targeting an aggregate dividend of 6.0 pence per share for the first 12 months from Admission which equates to a yield of 6 per cent. per annum on the IPO Issue Price, payable in quarterly instalments(1).
The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, Specialist Fund Segment, on 7 March 2017.
(1) This is a target only and not a profit forecast and there can be no assurance that it will be met and it should not be taken as an indication of the Group's actual or expected future results.